- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: BRAF Fusions
Total 1173 results
-
Mayo ClinicEnrolling by invitation
-
Institut du Cancer de Montpellier - Val d'AurelleMerck Serono International SACompleted
-
Universitair Ziekenhuis BrusselCompletedStage IV Melanoma | Stage III MelanomaBelgium
-
Massachusetts General HospitalIncyte CorporationTerminated
-
Ohio State University Comprehensive Cancer CenterNovartis Pharmaceuticals; National Comprehensive Cancer NetworkCompletedStage IIA Rectal Cancer | Stage IIB Rectal Cancer | Stage IIC Rectal Cancer | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Recurrent Rectal CancerUnited States
-
Fondazione Melanoma OnlusWithdrawn
-
CelltrionCompletedHealthy SubjectKorea, Republic of
-
Fudan UniversityCompletedThe Patients With CRLM Who Benefit More From BevacizumabChina
-
Technische Universität DresdenTerminatedBrain Metastases | Malignant Melanoma Stage IV | BRAF V600 MutationGermany
-
Fundacion para la Investigacion Biomedica del Hospital...Completed
-
Jiangsu Gensciences lnc.Completed
-
Memorial Sloan Kettering Cancer CenterArray BioPharmaCompletedAdvanced BRAF Mutant CancersUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedBlastic Plasmacytoid Dendritic Cell NeoplasmUnited States
-
Melanoma Institute AustraliaMerck Sharp & Dohme LLC; NovartisActive, not recruiting
-
Melanoma Institute AustraliaActive, not recruiting
-
Novartis PharmaceuticalsCompletedMelanomaUnited States, Belgium, Canada, Spain, United Kingdom, Netherlands, Argentina, Australia, Austria, Brazil, Czechia, Denmark, France, Germany, Greece, Israel, Italy, Japan, New Zealand, Norway, Poland, Russian Federation, Sweden, Switz... and more
-
Fred Hutchinson Cancer CenterPfizerCompletedAcute Myeloid LeukemiaUnited States
-
Zhengzhou Gensciences IncJiangsu Gensciences lnc.Completed
-
Assistance Publique - Hôpitaux de ParisCompletedDisease or R Group HistiocytosesFrance
-
Jiangsu Gensciences lnc.Completed
-
University of Texas at AustinEnrolling by invitation
-
Shanghai Henlius BiotechActive, not recruitingAnaplastic Thyroid Cancer | ATCChina
-
Novartis PharmaceuticalsCompletedCancerFrance, Spain, Netherlands, Canada, Austria, United States, Germany, Italy, Japan, Norway, Korea, Republic of, Denmark, Sweden, Belgium
-
Shanghai Henlius BiotechActive, not recruiting
-
National Institute of Allergy and Infectious Diseases...CompletedHIV Infections | Kidney DiseasesUnited States
-
xCuresCancer CommonsAvailableExpanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered MalignanciesMelanoma | Head and Neck Cancer | Glioblastoma | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Small Bowel Cancer | Ovarian Cancer | Non Small Cell Lung Cancer | Cholangiocarcinoma | Bladder Cancer | Thyroid Cancer | ERK Mutation | MAPK Gene Mutation | KRAS Activating... and other conditionsUnited States
-
PfizerCompletedMelanoma and Metastatic Colorectal CancerUnited States, Spain, France, Japan, Australia, Switzerland, Norway
-
University of Southern CaliforniaNational Cancer Institute (NCI); Vasgene Therapeutics, IncTerminatedStage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Pancreatic Adenocarcinoma | Head and Neck Squamous Cell Carcinoma | Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer | Metastatic Pancreatic Adenocarcinoma | Stage III Pancreatic Cancer | Stage... and other conditionsUnited States
-
Washington University School of MedicineTerminatedFollicular LymphomaUnited States
-
Novartis PharmaceuticalsCompletedBRAF Positive Metastatic MelanomaUnited States
-
Shanghai Henlius BiotechActive, not recruitingLangerhans Cell Histiocytosis | Erdheim-Chester Disease | LCH | ECDChina
-
Shanghai Henlius BiotechActive, not recruitingMetastatic Colorectal Cancer | mCRCChina
-
Hoffmann-La RocheTerminatedDigestive System Diseases | Gastrointestinal Diseases | Melanoma | Sarcoma | Neoplasms | Respiratory Tract Diseases | Neoplasms by Site | Gastrointestinal Neoplasms | Digestive System Neoplasms | Head and Neck Neoplasms | Respiratory Tract Neoplasms | Thoracic Neoplasms | Carcinoma, Bronchogenic | Bronchial Neoplasms and other conditionsUnited States
-
AlexionWithdrawn
-
Institut de Cancérologie de LorraineCompleted
-
Sun Yat-sen UniversityActive, not recruiting
-
Tianhong LiNational Cancer Institute (NCI); OncoImmune, Inc.TerminatedAdvanced Malignant Solid NeoplasmUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Northwestern University; Northwell Health; Dana-Farber... and other collaboratorsActive, not recruitingHairy Cell LeukemiaUnited States
-
Intergroupe Francophone de Cancerologie ThoraciqueCompletedCarcinoma, Non-Small-Cell Lung | KRAS Gene Mutation | ALK Gene Mutation | BRAF Gene MutationFrance
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...Completed
-
Grupo Español Multidisciplinar de MelanomaPierre Fabre Medicament; MFARActive, not recruitingMetastatic Melanoma | Brain MetastasesSpain
-
Tel-Aviv Sourasky Medical CenterCompleted
-
Hoffmann-La RocheCompletedMetastatic CancersSpain
-
Rain Oncology IncTerminatedNSCLC Stage IIIB | NSCLC, Recurrent | NRG1 Fusion | EGFR Exon 20 Insertion Mutation | NSCLC, Stage IIIC | NSCLC, Stage IV | HER2-activating Mutation | ERBB FusionUnited States, Canada, Hong Kong
-
Stryker Trauma GmbHTerminatedNeuropathy | Charcot; Disease (Etiology)United States
-
University of Southern CaliforniaNational Cancer Institute (NCI)WithdrawnRecurrent Bladder Carcinoma | Bladder Cancer Stage 0 | Bladder Cancer Stage IUnited States
-
Revolution Medicines, Inc.SanofiCompletedSolid TumorUnited States, Korea, Republic of
-
Beth Israel Deaconess Medical CenterMassachusetts General Hospital; Rambam Health Care Campus; Dana-Farber Cancer... and other collaboratorsCompletedMultiple MyelomaUnited States, Israel
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruitingLocally Advanced Melanoma | Unresectable Melanoma | Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 | Clinical Stage IV Cutaneous Melanoma AJCC v8 | Pathologic Stage IV Cutaneous Melanoma AJCC v8United States
-
Beth Israel Deaconess Medical CenterBristol-Myers Squibb; Dana-Farber Cancer InstituteTerminatedMultiple MyelomaUnited States